色多多下载官方版_色多多app最新版下载_色多多深夜福利免费观看_色多多网站入口官方版下载

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
The CFDA: 2 drug firms initiate an investigation, stop pin, recalled products
 
Author:中國(guó)銘鉉 企劃部  Release Time:2017-3-4 10:00:16  Number Browse:579
 
Medical network - on March 3, March 2, total bureau of national food drug safety alerts, 2 companies 6 batches of unqualified drugs sampling (see attachment). Followed, administration request product sales suspension, recall; To implement enterprise investigation and punishment to the people. 
 
This is since February 24, held a national work conference on drug sampling in chengdu after administration of notice substandard drugs for the first time. 
 
At the meeting, wu zhen, deputy director stressed: the sampling substandard medicines, risk control products in time, the first time according to the risk and take off the shelves, storage and recall measures. Administration will be released a week notice period sampling, unqualified products available to the public for inquiry, accept supervision from the public and to always check out the unqualified drugs carry out tracking sampling, as the inspection object, to ensure the rectification in place. 
 
The principle of sampling, reflected in the announcement. 
 
For 2 companies 6 batches sampling observation of unqualified drugs, administration said the relevant provinces, autonomous regions and municipalities directly under the food and drug administration has taken seized seized control measures, such as requiring companies to suspend sales use, recalls, and rectification. 
 
Food drug administration and administration for Tibet, shanxi illegal activities of production and sales of unqualified products to initiate an investigation, the punishment decision within one month, will be the penalty report administration and to the public. All the punishment shall be punishment to those responsible. 
 
As a result, can see clearly the thinking of drug regulatory, on the one hand control source -- are substandard medicines, penalties and related enterprises, have the effect of warning, so as to improve the quality levels of pharmaceutical production; Published on the other hand, with the market restriction, unqualified products information, into a unified database, convenient public inquiries, under the pressure of fear lose market, make the enterprise more strictly control the quality of product. 
 
Both, unqualified drugs is hard. Predictably, this administration of such notice will be intensive, in the long run, it will be great help for improve the quality of medicines. 

 
Previous article:Patrol launch 2017 national large hospital, the key to check two votes!
Next article:Improve the system of nationality medicine registration, timely review right down
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網(wǎng)安備 44011202000029號(hào)